Schonfeld Strategic Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.56M | Sell |
7,133
-6,564
| -48% | -$1.44M | 0.01% | 1025 |
|
2025
Q1 | $3.07M | Buy |
+13,697
| New | +$3.07M | 0.02% | 645 |
|
2024
Q1 | – | Sell |
-4,600
| Closed | -$1.62M | – | 2236 |
|
2023
Q4 | $1.62M | Buy |
+4,600
| New | +$1.62M | 0.01% | 805 |
|
2023
Q3 | – | Sell |
-5,914
| Closed | -$2.26M | – | 2146 |
|
2023
Q2 | $2.26M | Buy |
+5,914
| New | +$2.26M | 0.02% | 711 |
|
2023
Q1 | – | Sell |
-4,413
| Closed | -$1.04M | – | 2596 |
|
2022
Q4 | $1.04M | Sell |
4,413
-17,506
| -80% | -$4.12M | 0.01% | 1121 |
|
2022
Q3 | $5.39M | Buy |
+21,919
| New | +$5.39M | 0.05% | 507 |
|
2022
Q2 | – | Sell |
-2,462
| Closed | -$1.01M | – | 2935 |
|
2022
Q1 | $1.01M | Buy |
+2,462
| New | +$1.01M | 0.01% | 928 |
|
2021
Q2 | – | Sell |
-5,652
| Closed | -$1.59M | – | 2295 |
|
2021
Q1 | $1.59M | Buy |
5,652
+2,418
| +75% | +$682K | 0.02% | 699 |
|
2020
Q4 | $916K | Sell |
3,234
-1,407
| -30% | -$399K | 0.01% | 811 |
|
2020
Q3 | $1.28M | Buy |
+4,641
| New | +$1.28M | 0.02% | 605 |
|
2020
Q1 | – | Sell |
-3,150
| Closed | -$474K | – | 1560 |
|
2019
Q4 | $474K | Sell |
3,150
-4,773
| -60% | -$718K | 0.01% | 766 |
|
2019
Q3 | $1.12M | Buy |
+7,923
| New | +$1.12M | 0.03% | 446 |
|
2019
Q1 | – | Sell |
-10,444
| Closed | -$1.02M | – | 1303 |
|
2018
Q4 | $1.02M | Buy |
+10,444
| New | +$1.02M | 0.04% | 475 |
|
2018
Q2 | – | Sell |
-11,641
| Closed | -$1.03M | – | 989 |
|
2018
Q1 | $1.03M | Buy |
+11,641
| New | +$1.03M | 0.08% | 318 |
|
2017
Q3 | – | Sell |
-3,107
| Closed | -$294K | – | 777 |
|
2017
Q2 | $294K | Buy |
+3,107
| New | +$294K | 0.03% | 483 |
|
2017
Q1 | – | Sell |
-9,079
| Closed | -$770K | – | 757 |
|
2016
Q4 | $770K | Sell |
9,079
-10,631
| -54% | -$902K | 0.1% | 265 |
|
2016
Q3 | $1.47M | Buy |
+19,710
| New | +$1.47M | 0.25% | 111 |
|